Intriguingly, as a key modulator of upstream inflammatory pathways, IL-17 contributes to the production of IL-6, the elevated peripheral levels of which may initiate ME/CFS through neuroinflammation (6). This evidence concerns the gene IL17A and myalgic encephalomeyelitis/chronic fatigue syndrome.